Brain Diseases

Subtype terms (33)

More specific conditions that are subtypes of Brain Diseases in the MeSH hierarchy.

• Acute Febrile Encephalopathy

  37 drugs (23 approved, 14 experimental)

• Akinetic Mutism
• Amblyopia

  9 drugs (8 approved, 1 experimental)

• Amnesia, Transient Global
• Auditory Diseases, Central

  5 drugs approved

• Basal Ganglia Diseases

  7 drugs (1 approved, 6 experimental)

• Brain Abscess
• Brain Damage, Chronic
• Brain Death

  19 drugs (16 approved, 3 experimental)

• Brain Diseases, Metabolic

  1 drug experimental

• Brain Edema

  32 drugs (24 approved, 8 experimental)

• Brain Injuries

  117 drugs (92 approved, 25 experimental)

• Brain Neoplasms

  591 drugs (291 approved, 300 experimental)

• Cavernous Sinus Syndromes
• Cerebellar Diseases

  15 drugs (8 approved, 7 experimental)

• Cerebrovascular Disorders

  83 drugs (58 approved, 25 experimental)

• Dementia

  252 drugs (145 approved, 107 experimental)

• Diaschisis
• Diffuse Cerebral Sclerosis of Schilder

  1 drug experimental

• Encephalitis

  35 drugs (25 approved, 10 experimental)

• Encephalomalacia

  1 drug approved

• Epilepsy

  202 drugs (133 approved, 69 experimental)

• Headache Disorders

  21 drugs (16 approved, 5 experimental)

• Hydrocephalus

  18 drugs (16 approved, 2 experimental)

• Hypothalamic Diseases

  5 drugs (3 approved, 2 experimental)

• Hypoxia, Brain

  15 drugs (14 approved, 1 experimental)

• Intracranial Hypertension

  11 drugs (9 approved, 2 experimental)

• Intracranial Hypotension

  3 drugs (2 approved, 1 experimental)

• Leukoencephalopathies

  1 drug experimental

• Neuroaxonal Dystrophies

  2 drugs (1 approved, 1 experimental)

• Sepsis-Associated Encephalopathy

  3 drugs approved

• Subdural Effusion
• Thalamic Diseases

Drugs by status

Organizations

ICD-10 crosswalk

• G93.40 — Encephalopathy, unspecified